A Study of CI-1012 in HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

CI-1012

Trial Locations (4)

Natl Institutes of Health, Bethesda

Central Florida Research Initiative, Maitland

ViRx Inc, Palm Springs

ViRx Inc, San Francisco

All Listed Sponsors

lead

Parke-Davis

INDUSTRY

NCT00002196 - A Study of CI-1012 in HIV-Infected Patients | Biotech Hunter | Biotech Hunter